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Dopamine and nitric oxide systems can interact in different processes in the central nervous system. Dopamine and oxidation products have been
related to mitochondrial dysfunction. In the present study, intact mitochondria and submitochondrial membranes were incubated with different DA
concentrations for 5 min. Dopamine (1 mM) increased nitric oxide production in submitochondrial membranes and this effect was partially prevented
in the presence of both DA and NOS inhibitor Nω-nitro-L-arginine (L-NNA). A 46% decrease in state 3 oxygen uptake (active respiration state) was
found after 15 mM dopamine incubation. When mitochondria were incubated with 15 mM dopamine in the presence of L-NNA, state 3 respiratory
rate was decreased by only 17% showing the involvement of NO. As shown for O2 consumption, the inhibition of cytochrome oxidase by 1 mMDA
was mediated by NO. Hydrogen peroxide production significantly increased after 15 mM DA incubation, being mainly due to its metabolism by
MAO. Also, DA-induced depolarization was prevented by the addition of L-NNA showing the involvement of nitric oxide in this process too. This
work provides evidence that in the studied conditions, dopamine modifies mitochondrial function by a nitric oxide-dependent pathway.
© 2007 Elsevier B.V. All rights reserved.Keywords: Dopamine; Mitochondrial respiration; Brain mitochondria; Nitric oxide; Mitochondrial membrane potential1. Introduction
It is generally known that dopamine (DA) loss represents the
main neurochemical alteration in Parkinson's disease. However,
DA itself has been shown to have a role in dopaminergic
neurodegeneration. The most commonly described mechanism
of DA toxicity is its own enzymatic oxidation by monoamine
oxidase, leading to hydrogen peroxide (H2O2) generation which
causes oxidative stress and increases lipid and protein pero-
xidation [1]. The disruption of mitochondrial processes by
catecholamines has been implicated in the mechanisms under-
lying neurodegeneration in Parkinson's disease [2]. It has been
shown that dopamine (DA) is able to induce mitochondrial
dysfunction by a decrease in respiratory complex I activity,
induction of mitochondrial swelling and alteration of mito-
chondrial membrane potential [2–4]. Different mechanisms of
action of dopamine on mitochondrial function have been de-
scribed depending on drug concentration and time of exposure⁎ Corresponding author. Tel./fax: +54 11 4508 3646.
E-mail address: slarnaiz@ffyb.uba.ar (S. Lores-Arnaiz).
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doi:10.1016/j.bbabio.2007.07.005[5,6]. For instance, Gluck et al. [4] have proposed that inhibition
of brain mitochondrial respiration by 0.5 mM DA would be
mediated by H2O2 generation by MAO, while incubation of
brain mitochondria with 5–20 mM DA can inhibit mitochon-
drial oxygen consumption mainly by quinone oxidation [7].
Dopamine, acetylcholine and NO systems interact to induce
corticostriatal synaptic plasticity [8]. Also, Melis and colleagues
[9] reported that dopamine agonists increase nitric oxide
synthase (NOS) activity in the cell bodies of paraventricular
nucleus of the hypothalamus. Recently, it has been described
that phasis dopaminergic transmission increases NO efflux in
the rat dorsal striatum via a neuronal NOS [10].
Nitric oxide (NO) is produced in mitochondria by a mito-
chondrial nitric oxide synthase called mtNOS [11,12] and it has
important implications for the metabolism of cellular energy
[13] mainly by acting as a modulator of mitochondrial respi-
ratory chain.
The aim of this study was to evaluate the possible interaction
between dopamine and nitric oxide systems, and its impact on
mitochondrial function using a broad range of dopamine con-
centrations. Oxygen consumption, hydrogen peroxide produc-
tion, cytochrome oxidase activity and mitochondrial membrane
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function.2. Materials and methods
2.1. Animals
Three months female Swiss mice (20–25 g) from the animal facility of the
School of Pharmacy and Biochemistry were used. Animals were housed in an
environmentally controlled room and allowed free access to food and water.
Animal treatment was carried out in accordance with the guidelines of the
National Institute of Health (USA) for the care and use of laboratory animals
(NIH Publ. 8023, 1996). All efforts were made to minimize suffering and reduce
the number of animals used.
2.2. Preparation of synaptosome-free mitochondria
Experimental groups of 6 mice were used. Brains from 2 mice were pooled
for each experimental point. Tissues were weighed and homogenized (1:5 w/v)
in a medium consisting of 0.23 M mannitol, 0.07 M sucrose, 10 mM Tris–HCl
and 1 mMEDTA, pH 7.4. Homogenates were centrifuged at 700×g for 10 min to
discard nuclei and cell debris and the pellet was washed to enrich the supernatant
that was centrifuged at 8000×g for 10 min. The resulting pellet, containing both
synaptic and non-synaptic mitochondria, was able to carry out oxidative phos-
phorylation [14]. Further mitochondrial purification was performed by Ficoll
gradient [15]. All the procedure was carried out at 0–2 °C. Mitochondria were
submitted to twice freezing and thawing conditions and passed through hypo-
dermic needle [16], and the preparation obtained consisted of a fraction of
submitochondrial membranes which do not present any sideness or restriction to
substrate access. Protein content was assayed by using the Folin phenol reagent
and bovine serum albumin as standard [17].
For mitochondrial membrane potential determinations, brains were removed
and homogenized in MSH buffer (0.21 M mannitol, 0.07 M sucrose, 5 mM
HEPES, pH 7.4) supplemented with 1 mM EDTA. Homogenates were centri-
fuged at 600×g for 10 min at 4 °C. The supernatant was decanted and
centrifuged at 6000×g for 10 min to form a mitochondrial pellet that was
resuspended in MSH buffer without EDTA and centrifuged again at 6000×g for
10 min [18]. The final pellet was resuspended in MSH buffer at a protein
concentration of 20–25 mg/ml.
2.3. Measurement of nitric oxide production
Nitric oxide production was measured in submitochondrial membranes
using a spectrophotometric method by following the oxidation of oxyhemoglo-
bin (HbO2) to methemoglobin (metHb) at 37 °C. The NO assay was performed
using a Beckman-Coulter Serie DU 7400 diode array spectrophotometer in
which the active wavelength is set at 577 nm and the reference wavelength at the
isosbestic point at 591 nm (ε=11.2 mM−1 cm−1) [16]. The method is based on
the original assay developed by Murphy and Noack [19] for perfused organs in
which the HbO2 γ band is used to follow NO production. The α band is more
suitable for high light scattering conditions of cellular and mitochondrial
suspensions due to the close vicinity of the active (577 nm) and the reference
(591 nm) wavelengths [16].
The measurements were carried out in a reaction medium containing
50 mM phosphate buffer pH 5.8, 1 mM CaCl2, 50 μM L-arginine, 100 μM
NADPH, 10 μM DTT, 4 μM Cu–Zn superoxide dismutase (SOD), 0.1 μM
catalase, 0.5–1.0 mg submitochondrial protein/ml and 25 μM oxyhemoglobin
(expressed per heme group).
Oxyhemoglobin reacts efficiently with NO if the reaction between NO and
superoxide anion (O2
−) is prevented. Superoxide dismutase is added to abrogate
any other reaction with O2
−, including a direct oxidation of HbO2 to metHb or
reduction of metHb to Hb. In the presence of SOD, H2O2 could be produced.
H2O2 can oxidize both HbO2 and metHb to higher oxidation states. For this
reason, catalase is added to the assay [19].
Controls adding 0.5 mM Nω-nitro-L-arginine (L-NNA) and 0.5 mM N-nitro-
L-arginine-methyl-ester (L-NAME) as NOS inhibitors were performed in allcases to give specificity to the assay; addition of L-NNA and L-NAME inhibited
by about 73% and 50% the rate of hemoglobin oxidation respectively.
2.4. Evaluation of respiratory complexes activity
NADH-cytochrome c reductase activity (complex I+ III) was measured in
brain submitochondrial membranes by following spectrophotometrically the
reduction of cytochrome c at 30 °C at 550 nm (ε=19.6 mM−1 cm−1) in a reaction
medium containing 100mMphosphate buffer (pH 7.4), 0.2 mMNADH, 0.1 mM
cytochrome c and 0.5 mM KCN. Enzyme activity was expressed in nmoles
cytochrome c reduced per minute per mg of protein. Succinate cytochrome c
reductase activity (complex II+ III) was similarly determined and expressed,
except that NADH was substituted by 20 mM succinate.
Cytochrome oxidase activity (complex IV) was assayed spectrophotomet-
rically at 550 nm by following the rate of oxidation of 50 μM ferrocytochrome c
[20]. The activity was expressed as nmoles ferrocytochrome c oxidized per
minute per mg of protein.
2.5. Oxygen consumption
A two-channel respirometer for high-resolution respirometry (Oroboros
Oxygraph, Paar KG, Graz, Austria) was used. Mitochondrial respiratory rates
were measured in a reaction medium containing 0.23 M mannitol, 0.07 M
sucrose, 20 mM Tris–HCl (pH 7.4), 1 mM EDTA, 4 mM MgCl2, 5 mM
phosphate and 0.2% bovine serum albumin at 37 °C. Malate 6 mM and
glutamate 6 mMwere used as substrates to measure state 4 respiration and 1 mM
ADP was added to measure state 3 respiration [21].
The respiratory control ratio (state 3 respiration/state 4 respiration) was
determined [22].
2.6. Measurement of hydrogen peroxide production
Hydrogen peroxide generation was determined in intact brain mitochondria
(0.1–0.3 mg protein/ml) by the scopoletin-HRP method, following the decrease
in fluorescence intensity at 365–450 nm (λexc–λem) at 37 °C [23]. The reaction
medium consisted of 0.23 M mannitol, 0.07 M sucrose, 20 mM Tris–HCl (pH
7.4), 0.8 μMHRP, 1 μM scopoletin, 6 mMmalate, 6 mM glutamate and 0.3 μM
SOD. Superoxide dismutase was added in order to minimize ONOO− pro-
duction by interaction of NO with O2
−. A calibration curve was made using H2O2
(0.05–0.35 μM) as standard to express the fluorescence changes as nmol H2O2/
min mg protein.
2.7. Mitochondrial membrane potential
Mitochondria (0.25 μg/ml) were loaded with 30 nM of the potentiometric
cationic probe DiOC6 during 20 min at 37 °C and immediately 20000 events
were acquired by a FAC-SCAN flow cytometer equipped with a 488-nm argon
laser and a 615-nm red diode laser. Mitochondrial fluorescence with no probe
and after FCCP treatment was measured as negative and positive controls
respectively. Data from the experiments were analyzed using the CellQuest
software (Becton and Dickinson).
2.8. Drugs and chemicals
Dopamine, ADP, L-arginine, catalase, dithiothreitol, EDTA, glutamic acid,
malic acid, mannitol, NADPH, Nω-nitro-L-arginine, N-nitro-L-arginine-methyl-
ester, haemoglobin, scopoletin, horseradish peroxidase, succinate, sucrose,
superoxide dismutase, cytochrome c, trizma base and were purchased from
Sigma Chemical Co. (St. Louis, Missouri). Other reagents were of analytical
grade.
2.9. Statistics
Results are expressed as mean values±SEM. Student's t test was used to
analyze the significance of differences between paired groups. ANOVA was
used to analyze differences between mean values of more than two groups, as
described at the bottom of the tables.
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3.1. Effect of dopamine on mitochondrial enzyme activity
3.1.1. Nitric oxide synthase activity
Nitric oxide production was measured in control brain sub-
mitochondrial membranes and after 5 min incubation at 37 °C
with different DA concentrations. Fig. 1a shows that low
concentrations of DA (2–500 μM) were not able to modify NO
production as compared with control submitochondrial mem-
branes. However, incubation of submitochondrial membranes
with 1 mM and 15 mM DA significantly increased NO produc-
tion by approximately 2-fold and 3-fold respectively as com-
pared with control values (0.30±0.04 nmol/min mg protein).
In order to evaluate the direct effect of DA onmtNOS activity,
we measured NO production in the presence of two different
NOS inhibitors: L-NNA and L-NAME. A typical response of
inhibition of NO production was observed in control submito-
chondrial membranes after incubation with both 0.5 mM L-NNAFig. 1. mtNOS activity in control and dopamine-incubated brain submitochondrial m
submitochondrial membranes. Submitochondrial membranes were incubated for 5 mi
individual submitochondrial membranes samples, each obtained from a pool of two
compared with control submitochondrial membranes. (b) Effect of incubation of brain
NO production. Submitochondrial membranes were incubated for 5 minutes with 1
L-NAME at 37 °C. Bars represent the mean±SEM of 3 individual submitochond
followed by Tukey test was used (F=21.557) ⁎pb0.01, significantly different from
control submitochondrial membranes+L-NNA. ⁎⁎pb0.05, significantly different fand 0.5 mM L-NAME (Fig. 1b). The inhibitory effect of L-NNA
on mitochondrial NO production was more important than the
effect of L-NAME, possibly due to its higher specificity for brain
nNOS inhibition as reported [24]. In the presence of L-NNA,
incubation of submitochondrial membranes with 1 mM and
15 mM DA increased NO production by 87% and 162% res-
pectively, as compared with control submitochondrial mem-
branes incubated with L-NNA. Also, in the presence of L-NAME
and 1 mM dopamine an 80% increase in NO production was
observed, as compared with control+L-NAME values.
Similar results were obtained by measuring NO production
using a spectrophotometric method based on the detection of the
NO–HRP complex (data not shown) [25].
3.1.2. Respiratory complexes activity
Incubation of submitochondrial membranes with 1 mM DA
inhibited NADH-cytochrome c reductase activity by 20% as
compared with control submitochondrial membranes (326±
7 nmol/min mg protein). In contrast, no significant changesembranes. (a) Effect of dopamine incubation on NO production activity in brain
n with different DA concentrations at 37 °C. Bars represent the mean±SEM of 3
brains. ANOVA followed by Dunnett test was used (F=6.464). ⁎pb0.05, as
submitochondrial membranes with both dopamine and L-NNA or L-NAME on
mM and 15 mM DA in the presence or absence of 0.5 mM L-NNA or 0.5 mM
rial membranes samples, each obtained from a pool of two brains. ANOVA
control submitochondrial membranes. #pb0.01, significantly different from
rom control submitochondrial membranes+L-NAME.
Table 2
Effect of dopamine on brain mitochondrial respiration
Condition Oxygen consumption
(ng-at O/min mg protein)
Respiratory
control
Control (state 4) 18±4
+ ADP (state 3) 92±4 5.1±0.2
Dopamine 25 μM (state 4) 17±5
+ ADP (state 3) 80±6 4.7±0.3
Dopamine 50 μM (state 4) 15±7
+ ADP (state 3) 84±3 5.5±0.5
Dopamine 75 μM (state 4) 13±3
+ ADP (state 3) 90±7 5.4±0.2
Dopamine 5 mM (state 4) 21±4
+ ADP (state 3) 78±4 3.7±0.2
Dopamine 10 mM (state 4) 20±1
+ ADP (state 3) 68±3⁎ 3.40±0.06
Dopamine 15 mM (state 4) 19.5±0.4
+ ADP (state 3) 52±5⁎ 2.67±0.09#
Brain mitochondria were incubated with different DA concentrations during
5 minutes at 30 °C before measurements.
Values represent the mean±SEM of 3 individual mitochondria samples, each
obtained from pools of two brains.
ANOVA followed by Tukey tests was used (F=9.047).
⁎pb0.01, as compared to basal state 3 control value.
#pb0.05, as compared to control value.
Table 1
Effect of dopamine incubation on activity of mitochondrial respiratory chain
complexes in brain submitochondrial membranes
Activity (nmol/min mg protein) Control Dopamine (1 mM)
NADH-cytochrome c reductase 326±7 290±3⁎
Succinate-cytochrome c reductase 176±5 155±6
Submitochondrial membranes were incubated for 5 minutes with 1 mM DA at
30 °C before measurements.
Values represent the mean±SEM of 3 individual submitochondrial membranes
samples, each obtained from a pool of two brains.
Student's test was used (t=2.689).
⁎pb0.05, significantly different from control submitochondrial membranes.
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after DA incubation (Table 1).
Cytochrome oxidase activity was significantly inhibited by
21% after incubation of submitochondrial membranes with
1 mMDA. To evaluate the involvement of NO in this process we
measured enzyme activity in the presence of both DA and
L-NNA. Fig. 2 shows that the inhibitory effect of DA on cyto-
chrome oxidase observed previously was partially prevented by
L-NNA addition.
3.2. Effect off dopamine on mitochondrial function
3.2.1. Mitochondrial respiration
Malate-glutamate-dependent oxygen consumption rate was
measured in state 3 and state 4. State 3, termed active respi-
ration, is defined as respiration in the presence of an oxidizable
substrate and ADP and thus is a measure of the coupled res-
piration. State 4, or resting respiration, is the rate of respiration
in the presence of substrate but without ADP and thus is a
measure of the rate of uncoupled respiration [21].
Low DA concentrations (25–75 μM) were not able to mo-
dify mitochondrial respiratory rates, as compared with control
mitochondria (Table 2).Fig. 2. Dopamine effect on cytochrome oxidase activity. Submitochondrial
membranes were incubated for 5 min with 1 mM DA in the presence or absence
of 0.5 mM L-NNA at 30 °C. Bars represent the mean±SEM of 3 individual
submitochondrial membranes samples, each obtained from a pool of two brains.
ANOVA followed by Tukey test was used (F=31.965) ⁎pb0.01, significantly
different from control submitochondrial membranes. #pb0.05, significantly
different from control submitochondrial membranes+L-NNA.Incubation of intact brain mitochondria with different DA
concentrations (5–10–15 mM) for 5 min inhibited state 3
oxygen consumption in intact brain mitochondria by 19%, 28%
and 46% respectively, but no significant changes were
observed in state 4 after DA incubation (Table 2). Respiratory
control is a parameter of integrity and mitochondrial function-
ality [21]. A significant decrease in mitochondrial respiratory
control was observed after incubation with 15 mM DA as
compared with control mitochondria, indicating mitochondrial
dysfunction.
In order to evaluate the involvement of NO on the inhibition
of mitochondrial state 3 respiratory rate by DA, we measured
state 3 oxygen consumption in the presence of L-NNA both in
control or DA-incubated mitochondria. L-NNA addition alone
increased state 3 mitochondrial respiratory rate by 35%, as
compared with control state 3 respiratory rate. This agrees with
previous results from our laboratory showing that NO exerts a
regulatory effect on mitochondrial respiration [14]. When
mitochondria were incubated with 15 mM DA in the presence
of L-NNA, state 3 respiratory rate was decreased by 17%, as
compared with control+L-NNA (Fig. 3).
Note that intact brain mitochondria required higher dopa-
mine concentrations than submitochondrial membranes, prob-
ably because inner mitochondrial enzymes are less accessible to
the drug. All the experiments were carried out considering this
point. So, for further studies, intact mitochondria and sub-
mitochondrial membranes were incubated with 15 mM and
1 mM DA respectively.
3.2.2. Hydrogen peroxide production
Incubation of intact brain mitochondria with 15 mM DAwas
able to increase H2O2 production rates by 87%, as compared
with control H2O2 production rates (0.30±0.04 nmol/min mg
Table 3
Effect of dopamine on brain mitochondrial H2O2 production rate
H2O2 production (nmol/min mg protein) Control Dopamine (15 mM)
Malate–Glutamate 0.30±0.04 0.56±0.02⁎
+0.5 mM L-NNA 0.21±0.01 0.36±0.04⁎
Mouse brain mitochondria were incubated with 15 mM DA during 5 min at
37 °C before measurements.
Values represent the mean±SEM of 3 individual mitochondria samples, each
obtained from pools of two brains.
ANOVA followed by Tukey tests was used (F=23.811).
⁎pb0.05, significantly different from its corresponding control value.
Fig. 3. Evaluation of state 3 respiration after dopamine incubation. Intact brain
mitochondria were incubated during 5 min at 30 °C with 15 mM DA in the
presence or absence of 0.5 mM L-NNA. Bars represent the mean±SEM of 3
individual submitochondrial membrane samples, each obtained from a pool of
two brains. ANOVA followed by Tukey test was used (F=36.274). ⁎pb0.01,
significantly different from control submitochondrial membranes. #pb0.01,
significantly different from control submitochondrial membranes+L-NNA.
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by 30% in control brain mitochondria as previously shown by
our laboratory [14]. In the presence of L-NNA, DA increased
H2O2 production rates by 68% (Table 3).
3.2.3. Mitochondrial membrane potential
After incubation with 15 mM DA an important decrease in
FL-1-DiOC6 fluorescence was observed (Fig. 4d) as compared
with control mitochondria (Fig. 4c), indicating mitochondrial
depolarization. Incubation with 50 μM DA did not disturb
mitochondrial polarization (Fig. 4e). The involvement of NO on
these effects was evaluated by incubation of mitochondria with
both DA and L-NNA. No changes in mitochondrial polarization
were observed after L-NNA incubation in control mitochondria
(Fig. 4f). A clear inhibition of the 15-mM DA-induced depo-
larization was observed in the presence of L-NNA (Fig. 4g)
showing the possible role of NO in DA-induced loss of mito-
chondrial membrane potential. No changes were observed after
both 50 μM DA and L-NNA incubation (Fig. 4h). Addition of
the ionophore FCCP (0.5 μM) to brain mitochondria showed
stronger decrease in transmembrane potential (Fig. 4i). Un-
loaded control mitochondria present a low auto fluorescence as
observed in Fig. 4b.
Statistical values of the relative fluorescence intensity
showed that control mitochondria presented 84±3% (Fig. 4c)
and after 15 mM and 50 μM DA incubation, FL-1-DiOC6
fluorescence was 20±5% and 83±4% respectively (Fig. 4d, e).
The data presented in Fig. 4j and k show that NO participate
in the 15-mM DA-induced depolarization due to the fact that
L-NNA was able to maintain mitochondrial polarization.
4. Discussion
Dopamine plays an important role in the physiopathology of
several psychiatric and neurological disorders such as schizo-phrenia and Parkinson's disease and in those cases disruption
of mitochondrial processes was observed [2].
Several studies on mitochondrial function following expo-
sure to DA have produced variable results. An inhibition of
respiration and a decrease in complex I activity after incubation
(5–15 min) with DA have been reported as a result of the
deleterious actions of H2O2 and oxyradicals [2,4,5,7]. Also,
Khan and colleagues [6] reported that extended periods of
incubation with DA produce mitochondrial dysfunction by DA
oxidation products. Due to the fact that catecholamines may
modify NO levels in central nervous system, in this study we
investigated the effects of incubation of mitochondria with DA
on NO production and the consequences on mitochondrial
function.
Due to the discrepancies concerning DA concentrations
observed in the literature, in our study, submitochondrial mem-
branes were incubated with a broad range of DA concentrations
(from μM to mM range) to evaluate its effects on NO pro-
duction. According to our results, low DA concentrations (range
μM) did not alter mitochondrial NO production. However, a
significant increase was observed in NO production after 1 mM
and 15 mM DA incubation. The striatal concentration of DA is
estimated to be about 70 μM, whereas the dopaminergic con-
centration in the neuronal endings and during the phasic release
is of the order of mM [26]. Cells with high DA concentrations
such as dopaminergic neurons are highly vulnerable to dege-
neration. It has been proposed that if DA is not efficiently stored
in vesicles or if vesicles are disrupted, it can achieve high
intracellular concentrations and may overcome the antioxidant
capacity of the cell [27]. Results reported in our study are
related to DA concentrations probably present in pathological
situations where an imbalance between cytosolic and vesicular
DA occurs.
Brain mtNOS has been previously identified byWestern Blot
as nNOS isoform [28] and its activity can be modified by drug
treatments [16]. DA-induced increase in NO production was
largely prevented by pre-treatment with NOS inhibitors, thus
showing a specific action of DA on mtNOS activity. Regarding
the mechanism of action of DA on mtNOS activity, we can
speculate that DA might interact with the enzyme in a site
different from the catalytic site, activating the enzyme, and thus
acting as an allosteric modulator. Further investigations on
enzymatic kinetics would help to elucidate the probable mecha-
nism of this activation.
Fig. 4. Dopamine effect on mitochondrial membrane potential. Histograms of gated events (R1) versus relative fluorescence intensity (FL-1) of mitochondrial
membrane potential of brain mitochondria described by DiOC6. (a) dotblot of FSC-H vs. SSC-H indicating a gated mitochondrial population, (b) unloaded, (c) control,
(d) 15 mMDA, (e) 50 μMDA, (f) 0.5 mM L-NNA, (g) 15 mMDA plus 0.5 mM L-NNA, (h) 50 μMDA plus 0.5 mM L-NNA, (i) 0.5 μM FCCP, (j) overlay histograms
of control, 15 mMDA and 15 mMDA plus L-NNA and (k) bars scheme ofΔψmitochondrial (Δψm) versus different DA treatments (mean values±SEM); (⁎pb0.01).
Each histogram represents a typical experiment, which was performed in triplicate.
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reversible and O2-competitive inhibition of cytochrome oxidase
that slows down electron flow, substrate oxidation and chemical
energy store [29]. Oxygen consumption was not affected by low
physiological DA concentrations, while high (mM) DA levels
decreased O2 consumption in state 3 and decreased respiratory
control in brain intact mitochondria. Gluck et al. [4] have
reported that DA at relatively low concentrations (0.5–3 mM)
inhibited mitochondrial respiration predominantly by a MAO-
dependent mechanism involving H2O2 and downstream hy-
droxyl radical formation. Inhibition of respiration by DA at
higher concentration (N3 mM), however, is progressively less
dependent on MAO, implying additional coexisting mechan-
isms that participate in the inhibition of respiration and electron
transport chain function. We are giving evidence of another
MAO-independent mechanism of DA-induced inhibition of
mitochondrial respiration.
In this study, mitochondria pre-treatment with L-NNA
partially prevented the decrease in oxygen uptake observed
after DA incubation. According to these results, DAwas able to
inhibit state 3 O2 consumption by a NO-dependent pathway.
The modulatory role of NO on mitochondrial respiratory chain
has been extensively described; L-NNA has been shown to
increase state 3 respiratory rate in mitochondria isolated from
different tissues. Also, previous results from our laboratory gave
evidence that drugs that inhibit mtNOS activity induce an
increase in state 3 respiratory rate [30].
Due to the fact that in this study DA decreased mitochondrial
respiratory rates, we decided to evaluate which mitochondrial
respiratory complexes were affected by the drug. As previously
reported by several authors [5,7], DAwas able to inhibit NADH-
cytochrome c reductase activity but no changes were observed
in succinate-cytochrome c reductase activity. Studies of patients
with Parkinson's disease demonstrate a 35% decrease in mito-
chondrial complex I activity [31] showing that DA is a potential
candidate that can contribute to both oxidative stress and mito-
chondrial dysfunction within the dopaminergic neuron leading
to cell damage and degeneration. The inhibition of mitochon-
drial respiration by NO at cytochrome oxidase level has been
established as a physiological regulatory mechanism of mito-
chondrial function [32,33]. Dopamine inhibited cytochrome
oxidase activity in submitochondrial membranes. When we
measured the activity in the presence of both DA and L-NNA the
inhibitory effect of DA on cytochrome oxidase activity was
partially prevented, suggesting that inhibition of complex IV
activity by DA results from an increase in NO production.
Hydrogen peroxide is normally formed during basal respi-
ration [34] and also is a product of DA metabolism by MAO
[35]. We found that 15 mM DA increased H2O2 production
significantly by 87%, being mainly due to NO-independent
mechanisms. Therefore, the main mechanism involved in the
increased H2O2 generation by DA seems to be caused by its
own autooxidation by MAO, while a small fraction of H2O2
increased production would be mediated through the inhibition
of cytochrome oxidase by DA-induced NO production.
Evaluation of the mitochondrial membrane potential shows
that high DA concentrations induce depolarization, while lowphysiological DA concentrations do not affect mitochondrial
membrane potential. This result is in accordance with the lack of
effect of low DA concentrations on mitochondrial NO pro-
duction and on respiratory rates, thus showing that mitochon-
drial function seems to be preserved at physiological DA
concentrations. Our data are consistent with an early work by
Berman and Hastings [2] who found that DA induce mitochon-
drial permeability transition and produce membrane depolar-
ization. In our study, in the presence of both DA and L-NNA an
inhibition of 15 mM DA-induced depolarization was observed.
It has been reported that NO induce depolarization in isolated
neuronal mitochondria [36] and in cortical neurons in culture
[37]. The results presented here support the idea that DA in-
duces depolarization by an increase in NO production.
To sum up, the data presented provide evidence that at phy-
siological DA concentrations, mitochondrial function and NO
production seem to be preserved. High DA concentrations in-
duce mitochondrial dysfunction as shown by decreased mito-
chondrial respiratory control and loss of membrane potential
mainly by a NO-dependent pathway.
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